Current status and protection strategies for the welfare of research participants after clinical trial completion
10.12026/j.issn.1001-8565.2026.08.03
- VernacularTitle:临床试验结束后研究参与者福利现状及其保障策略
- Author:
Weijia ZHOU
1
;
Jiyin ZHOU
2
Author Information
1. Office of Ethics Committee， Sichuan Cancer Hospital/Affiliate Cancer Hospital of University of Electronic Science and Technology of China， Chengdu 610041， China
2. Clinical Medical Research Center， the Second Affiliated Hospital of Army Medical University， Chongqing 400037， China
- Publication Type:Journal Article
- Keywords:
clinical trial;
research participant;
humanistic care;
welfare;
dignity
- From:
Chinese Medical Ethics
2026;39(8):998-1004
- CountryChina
- Language:Chinese
-
Abstract:
The safeguard system for research participants after clinical trial completion in China remains underdeveloped currently， mainly manifested in the lack of follow-up mechanisms， the absence of ethical review， and insufficient supervision by competent authorities， posing potential risks to the long-term welfare and rights and interests of research participants. To practically address this issue， it is necessary to establish a comprehensive and sustainable safeguard framework. It is recommended to clearly define the various welfare and rights and interests of research participants after trial completion， and to establish a scientific compensation mechanism， thereby laying a solid legal foundation for safeguarding work. A comprehensive follow-up system should be developed to provide long-term health monitoring， professional medical consultation， and necessary public education for research participants， with attention to their long-term health risks. It is also vital to strengthen the supervision role of ethical review throughout the entire process and establish a dynamic tracking mechanism for projects to ensure continuity after trial completion. By improving policies， building systems， strengthening oversight， and other aspects， a scientific， standardized， and humanistic clinical trial environment should be developed， ensuring that the rights and interests of every research participant can be fully respected and protected after trial completion.
